Earnings call. Here are some notes I took away from the conference call but don’t just take my word for it. Invest an hour of your time reviewing the presentation
https://auxly.com/wp-content/themes/auxly2018/media/Auxly_Investor_Presentation.pdf
and actually listen to the pod-cast yourself.
https://playback.conferenceconsole.com/recordings/rec22176767_20220331093351.mp3
————
79% Rev Growth YoY
23% Market Share - Cannabis 2.0
Achieve EBITDA positive through Increased Revenues and Improving margins - focus moving forward.
Sunens / Leamington 870,000 square feet now licensed, fully planted and in a continuous growing cycle.
24:00 - Sunens high efficiency will be positively reflected in improved margins starting in Q1
25:30 - Sunens now EBITDA positive post acquisition will result in significant improvements to EBITDA growing forward.
26:30 - Sunens related expect margins to improve to as much as 30% from current 23% begin reflecting in Q1.
29:15 - Lowest Vape failure rates.
-Kolab Project / Auxly Ottawa-
30:45 - Pre-roll Automated packaging equipment arrived end of February and is currently being Commissioned.
Higher pre-roll production rates will commence in Q2 further improving margins and EBITDA but due to supply line constraints and delays (I.e. packaging) full capacity pre-roll production may be further delayed , POSSIBLY pushing EBITDA positive out another quarter.
EBITDA Positive, forward guidance now more comfortable with Q3.
————-
Plenty more to note.
Lots of false info from certain posters here lately. Best to do your own DD.
Hope this helps cut through some of the BS.
cheers